ArticlePloS one2025
Exploring differential production of alkaloids and terpenoids in Cristataspora coffeata (Berk:) Robledo (Ganodermataceae) under submerged culture.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basidiomycetes are recognized for their capacity to produce a diverse range of secondary metabolites, particularly terpenoids and alkaloids, which have significant applications in the pharmaceutical, agricultural, and chemical industries. Among them, Cristataspora (formerly Humphreya) coffeata has attracted attention for its promising biosynthetic potential. Investigating the range of compounds produced by this fungus in controlled submerged culture conditions, rather than in the fruiting body stage, is particularly beneficial, as it enables precise control of environmental and nutritional factors, resulting in more consistent and scalable metabolite production. This study examined the differences in the cultivation of C. coffeata and the synthesis of terpenoids and alkaloids when the growth medium was supplemented with either glucose or lactose as a carbon source. It was observed that when the fungus was cultivated with glucose, the kinetic parameters did not differ from those with lactose. However, the individual pellet size was larger with glucose compared to lactose. Regarding secondary metabolites, in glucose cultures, a differential production of terpenoids and alkaloids was observed in the biomass and culture supernatant at 6 and 14 days, respectively, compared to lactose, as determined by TLC and spectrophotometric quantification. GC-MS analysis revealed that 19 differential compounds were detected in the biomass and 9 in the supernatant when glucose was used as the carbon source. In contrast, with lactose, 14 compounds were differentially produced in the biomass and 7 in the supernatant. These findings underscore the relevance of submerged cultivation for modulating secondary metabolite profiles and the importance of selecting the appropriate carbon source to maximize yields of target compounds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.